Available downloads
All links are direct pdf downloads of ECHO session presentations unless specified.
Important!
These files are provided for information only and are not intended to replace the clinical judgement of a practitioner. They should not be used alone to guide individual patient care.
Search
Results for "buprenorphine" tag.
Buprenorphine and Methamphetamine Use Disorder.
PDF
Buprenorphine and Methamphetamine Use Disorder.
Discusses evidence for the role of buprenorphine in methamphetamine use disorder.
Session date: November 15, 2023MATOD – A Tasmanian Perspective
Prenatal exposure to methadone or buprenorphine
PDF
Prenatal exposure to methadone or buprenorphine
An overview of the long-term effects of prenatal exposure to MATOD drugs.
Session date: March 16, 2022Transferring from Sublocade® to Buvidal®.
PDF
Transferring from Sublocade® to Buvidal®.
Important: this session was in response to a temporary global shortage of the 300mg strength of Sublocade® from November 2021.
Session date: December 1, 2021Transferring from methadone to long-acting injectable buprenorphine (LAIB).
PDF
Transferring from methadone to long-acting injectable buprenorphine (LAIB).
Special considerations when transferring patients from methadone to LAIB
Session date: December 8, 2021Buprenorphine for mental health.
PDF
Buprenorphine for mental health.
Does buprenorphine have a role in treating some mental health disorders?
Session date: September 15, 2021Overview of pharmacotherapies – methadone, buprenorphine incl. LAIB
PDF
Overview of pharmacotherapies – methadone, buprenorphine incl. LAIB
Session 3 of our foundation series
Session date: February 3, 2021Buprenorphine pharmacology
Buprenorphine-assisted withdrawal
PDF
Buprenorphine-assisted withdrawal
An overview of the use of buprenorphine to assist treatment of opioid withdrawal.
Session date: June 1, 2019